Pre header text goes here. Will show on inbox
To view this email as a web page, click here.

NPs and PAs in Dermatology
 
 
COMMENTARY
 
Treatment options for skin disorders
In our February Clinical Considerations, we take a look at treatment options for a few common skin disorders.
Read Joe Gorelick's takeaways
 
CLINICAL CONSIDERATIONS
 
Rosacea treatments
Dermatologists are rethinking some older therapies while awaiting new options under development.
Find out more
 
Laser and injectable options for treatment of keloids
Laser treatments, non-steroid injectables, and topical applications are proving to be effective in the treatment of keloids and excessive scarring.
Dermatologists should consider this data
 
FDA approves corticosteroid-sparing topical option for eczema
The FDA announced it has approved Eucrisa (Anacor Pharmaceuticals, crisaborole) to treat mild to moderate eczema in patients.
Learn more about the treatment
 
In case you missed it
 
Coding 2017 and beyond
How dermatologic research can get its groove back
Am I liable for a glitch in my EHR system?
 
DIGITAL EDITION
 
February Features
Keloid care, MCC treatment, EHR liability and more are all inside this month's issue of Dermatology Times.
Catch up on today's trends
 
JOB OPPORTUNITIES
 
 
 
 
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.